ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with

 

EVER Pharma UK Ltd - 2 May 2023

We are pleased to announce that, as of 2 May 2023, Alliance Healthcare UK will become the only wholesaler to supply selected products of EVER Pharma UK to all pharmacies, hospitals, and dispensing doctors in the United Kingdom.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK Launches Advisory Board

 

Alliance Healthcare UK is a leading wholesaler of medicines and healthcare products and serves over 17,000 healthcare providers including community pharmacies, GPs, hospitals, and health centres.


The Advisory Board consists of senior experts from the healthcare sector and provides an invaluable source of advice, ensuring Alliance Healthcare UK’s strategic programme is aligned to NHS priorities and delivers real value to UK patients. 


The Advisory Board is chaired by Alliance Healthcare UK’s Non-Executive Adviser, Chris Martin and has four members: Lord O’Shaughnessy, former Department of Health Minister and Director of the No.10 policy unit; Jeannette Howe, former head of Pharmacy at the Department for Health and Social Care; Claire Ward, Chair of Sherwood Forest Hospitals NHS Foundation Trust and former MP for Watford (1997 – 2010) who served as PPS for the Department for Health (2001-2005) and Justice Minister; Fin McCaul, Managing Director of Prestwich Pharmacy and Fellow of the Royal Pharmaceutical Society.


The Advisory Board has met twice this year at Alliance Healthcare UK’s headquarters in Chessington and will meet quarterly in 2023.


Marie Evans, Managing Director of Alliance Healthcare UK, said: “The Advisory Board is an invaluable resource, bringing great knowledge and experience to challenge Alliance Healthcare UK’s strategy as we continue to support community pharmacy and ensure that our service development priorities align to those of the NHS and improve the lives of patients.”

 

Find out more about our board members by clicking here.

 

 

SUB-TYPE:

Spring 2023 Bank Holiday Opening Hours

 

To help keep our customers informed of changes to our service, we have published our bank holiday opening hours for pharmacy and retail customers for the early Spring Bank Holiday period from Friday 26 May 2023 to Tuesday 30 May.

 

View our bank holiday opening hours:

Spring 2023 Bank Holiday Opening Hours for Pharmacy/Retail customers

 

May 2023 Bank Holiday Opening Hours for Alcura Homecare Deliveries

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Beconase Hayfever Nasal Spray 180 Dose (P)

Omega Pharma Ltd has identified that there is text missing in Section 2 of the Patient Information Leaflet (PIL) in packs of Beconase Hayfever Nasal Spray (P).

 

MHRA drug alert date: 26th April 2023

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-omega-pharma-ltd-beconase-hayfever-nasal-spray-el-23-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bcaed696-a02b-4ec1-bbed-8bd2b462dab8&utm_content=immediately

 

Pip code

Product Description

Affected Batches

2149839

 

BECONASE ALLERGY 180 SPRAYS

SEE LINK ABOVE

This is a caution in use only we are not accepting stock returns.

 

Further Information

For medical information, stock control queries and Patient Information Leaflet (PIL) requests, please contact: UKLOcustomerservice@perrigo.com

 

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension

Sandoz limited has informed the MHRA that the products mentioned in this notification are not sugar free despite the carton stating ‘sugar free’. The ‘sugar free’ text was added to the carton in December 2008 in error.

MHRA drug alert date: 20th April 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-limited-co-amoxiclav-125-slash-31-dot-25mg-slash-5ml-250-slash-62-dot-5mg-slash-5ml-powder-for-oral-suspension-el-23-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8bedc9fd-dd67-44c7-8691-89546eb2ed97&utm_content=immediately#contents

Pip code

Product Description

Livery

Affected Batches

1117290

 

CO-AMOXICLAV 125/31.25MG ALM

 

ALMUS

LL9525 LM7892 MB7218

 

1117308

 

CO-AMOXICLAV 250/62.5MG ALM

 

ALMUS

LM6707 LM7608 MB7828 MG9435

 

1117290

CO-AMOXICLAV 125/31.25MG

SANDOZ

SEE LINK ABOVE

1117308

CO-AMOXICLAV 250/62.5MG

SANDOZ

SEE LINK ABOVE

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For more information, medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101

 

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607

SUB-TYPE:

Early May and King Charles III Coronation Bank Holiday Opening Hours

 

To help keep our customers informed of changes to our service, we have published our bank holiday opening hours for pharmacy and retail customers, and bank holiday opening hours for hospital customers for the early May bank holiday and Coronation of King Charles III covering the period from 28 April to 9 May 2023.

 

View our bank holiday opening hours:

Early May 2023 Bank Holiday Opening Hours for Pharmacy/Retail customers

 

Early May 2023 Bank Holiday Opening Hours for Hospital customers

 

King Charles III Coronation Bank Holiday Opening Hours for Pharmacy/Retail customers

 

King Charles III Coronation Bank Holiday Opening Hours for Hospital customers

 

May 2023 Bank Holiday Opening Hours for Alcura Homecare Deliveries

SUB-TYPE:

Almus product wins Pharmacy Product of the Year 2023

 

Alliance Healthcare are proud and delighted to share that our own brand product, Almus Erectile Dysfunction Relief 50mg Film Coated Tablets, won Pharmacy Product of the Year 2023 (Sexual Health category) as voted by independent pharmacists in the UK. 

 

Run by the Independent Community Pharmacist magazine (part of the Communications International Group), the Pharmacy Product of the Year Awards celebrates their 13th year of recognising exceptional brands and their commitment to independent pharmacies as they strive to improve the service they offer to their patients. Independent pharmacists and, for the first time, consumers, have voted on the most popular and best-selling over the counter products in a range of categories in independent pharmacies across the country.

ed2PPOY

Tara Dew, Own Brand Manager says: “This is fantastic news for our own brand Almus OTC, and just shows how much we’ve grown as a brand over the last few years. This success follows on from last year’s MVP Awards, which the product was shortlisted for Most Valued Product of the Year 2022, together with Almus Ibuprofen and Codeine 200mg/12.8mg Tablets (32s) and Almus Cold Sore 1% w/w Cream”.

 

Click here to view the March issue of ICP magazine.

 

You can also view the full Pharmacy Product of the Year Winners feature here.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Briviact 75mg & 100mg film coated tablets

Ethigen Limited have informed the MHRA that the Patient Information Leaflet (PIL) in Briviact 75mg and Briviact 100mg film coated tablets contains incorrect or missing information.

 

MHRA drug alert date: 30th March 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ethigen-limited-briviact-75mg-and-100mg-film-coated-tablets-el-23-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=029a9973-e8e8-4dc1-99ae-a45b0b7f8b12&utm_content=immediately

 

 

Pip code

Product Description

Affected Batches

ALLIANCE HEALTHCARE DO NOT STOCK

BRIVIACT FILM COATED TABS 75MG

340132       332075

ALLIANCE HEALTHCARE DO NOT STOCK

BRIVIACT FILM COATED TABS 100MG

332076

329941

337225

332072

329491

337216

339975

337216

343194

349497

343190

349527

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For medical information and stock control queries please contact the Regulatory Affairs Department at regulatory@ethigen.co.uk.

 

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with Daiichi Sankyo: 01 May 2023

 

We are pleased to announce that, as of 01 May 2023, Alliance Healthcare UK will become the only wholesaler to supply Daiichi Sankyo’s product portfolio* to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland.

 

*ENHERTU will remain in its present distribution arrangement outside of this solus agreement.

 

Click here for full product details.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-GONAPEPTYL Depot 3.75mg

Reason: “Ferring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked 30-millimeter (30mm) needle for subcutaneous injection that is supplied with each product pack.”

 

MHRA drug alert date  23rd March 2023

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-ferring-pharmaceuticals-limited-gonapeptyl-depot-3-dot-75mg-powder-and-solvent-for-suspension-for-injection-el-23-a-slash-12

 

  • MHRA ref: MDR 065-03/23

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE HEALTHCARE DO NOT STOCK

GONAPEPTYL DEPOT PFS 3.75MG    

FERRING PHARMACEUTICALS

T16656K
U11271E
U11271F
U11386G
U11570E
U11571E
U15102C
U15102K
U15102L

 

Further Information

For all medical enquiries, please contact medical information: medical.uk@ferring.com.

For supply queries, please contact customer services: customer.services@ferring.com

 

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.